FDSSX
Price
$75.09
Change
+$0.05 (+0.07%)
Updated
May 9 closing price
Net Assets
6.46B
RGAHX
Price
$71.62
Change
-$0.09 (-0.13%)
Updated
May 9 closing price
Net Assets
285.48B
Ad is loading...

FDSSX vs RGAHX

Header iconFDSSX vs RGAHX Comparison
Open Charts FDSSX vs RGAHXBanner chart's image
Fidelity Stock Selec
Price$75.09
Change+$0.05 (+0.07%)
VolumeN/A
Net Assets6.46B
American Funds Growth Fund of Amer R5E
Price$71.62
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets285.48B
FDSSX vs RGAHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FDSSX vs. RGAHX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDSSX is a Buy and RGAHX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 285B vs. FDSSX (6.46B). FDSSX pays higher dividends than RGAHX: FDSSX (0.89) vs RGAHX (0.54). FDSSX was incepted earlier than RGAHX: FDSSX (35 years) vs RGAHX (9 years). FDSSX (0.44) and RGAHX (0.44) have similar cost to investors . RGAHX is a more actively managed with annual turnover of: 25.00 vs. FDSSX (3.00). FDSSX has a lower initial minimum investment than RGAHX: FDSSX (0) vs RGAHX (250). RGAHX annual gain was more profitable for investors over the last year : 3.25 vs. FDSSX (1.27). FDSSX return over 5 years is better than : 73.50 vs. RGAHX (44.87).
FDSSXRGAHXFDSSX / RGAHX
Total Expense Ratio0.440.44100%
Annual Report Gross Expense Ratio0.440.44100%
Fund Existence35 years9 years-
Gain YTD-5.106-2.478206%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets6.46B285B2%
Annual Yield % from dividends0.890.54163%
Returns for 1 year1.273.2539%
Returns for 3 years34.5633.40103%
Returns for 5 years73.5044.87164%
Returns for 10 years108.59N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARKO4.770.32
+7.19%
ARKO Corp
LYRA0.10N/A
+4.03%
Lyra Therapeutics
JJSF116.230.49
+0.42%
J & J Snack Foods Corp
CRL138.79-2.57
-1.82%
Charles River Laboratories International
FDMT3.08-0.16
-4.94%
4D Molecular Therapeutics